HCN4 gain-of-function mutation increases intrinsic heart rate and limits maladaptive remodeling under pressure

Konstantin Hennis1,2, Julia Rilling1, Linh Pham1

  • 1Department of Pharmacy - Center for Drug Research, Pharmacology for Natural Sciences, Ludwig-Maximilians Universität München, Munich, Germany.

Insights

Gain-of-function mutations in the HCN4 channel increase heart rate but do not cause cardiac damage. These mutations protect against heart problems during pressure overload, suggesting HCN4 activity can be adaptive.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology
  • Channelopathies

Background:

  • Gain-of-function (GOF) mutations in the HCN4 channel are linked to inappropriate sinus tachycardia.
  • Chronic tachycardia can lead to adverse cardiac remodeling and cardiomyopathy.
  • The impact of enhanced HCN4 activity on cardiac structure and function under stress is not well understood.

Purpose of the Study:

  • To investigate the effects of an HCN4 gain-of-function mutation on cardiac function and structure.
  • To determine if enhanced HCN4 activity influences cardiac remodeling during pressure overload.

Main Methods:

  • Generated HCN4(Y527F) knock-in mice (HCN4F) with a GOF mutation.
  • Performed electrophysiological recordings and telemetric ECGs.
  • Assessed cardiac structure and function via histology, contractility measurements, and RNA sequencing after transverse aortic constriction.

Main Results:

  • HCN4F mice exhibited elevated intrinsic heart rate and faster conduction without spontaneous arrhythmias or structural changes.
  • Under pressure overload, HCN4F mice showed preserved systolic function and reduced chamber dilatation compared to wild-type mice.
  • Gene expression analysis revealed distinct remodeling signatures between genotypes under stress.

Conclusions:

  • HCN4 GOF mutation increases heart rate without detrimental effects on cardiac structure or function.
  • Enhanced HCN4 activity provides protection against maladaptive cardiac remodeling during pressure overload.
  • These findings challenge the notion that elevated heart rate is always harmful and suggest a role for HCN4 in adaptive cardiac responses.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...